Globus Medical (GMED)
(Delayed Data from NYSE)
$50.37 USD
-1.07 (-2.08%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $50.35 -0.02 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for Globus Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 122.87 | 190.17 | 149.19 | 102.29 | 155.21 |
Depreciation/Amortization & Depletion | 225.36 | 73.64 | 72.65 | 63.46 | 51.65 |
Net Change from Assets/Liabilities | -116.60 | -105.26 | -17.25 | -37.59 | -73.44 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.87 | 19.92 | 71.69 | 70.64 | 38.56 |
Net Cash From Operating Activities | 243.50 | 178.47 | 276.27 | 198.79 | 171.98 |
Property & Equipment | -78.27 | -74.05 | -56.90 | -63.66 | -70.75 |
Acquisition/ Disposition of Subsidiaries | -296.03 | -31.44 | -34.49 | -33.48 | -23.80 |
Investments | 677.27 | -4.88 | -284.55 | -20.18 | -45.73 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 302.97 | -110.36 | -375.94 | -117.32 | -140.28 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -213.17 | -102.78 | 63.50 | -32.35 | 31.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -18.66 | -7.19 | -9.35 | -6.32 | -6.60 |
Net Cash from Financing Activities | -231.82 | -109.96 | 54.15 | -38.66 | 24.44 |
Effect of Exchange Rate Changes | 2.18 | -0.75 | -0.81 | 0.87 | -0.16 |
Net Change In Cash & Equivalents | 316.83 | -42.60 | -46.33 | 43.67 | 55.98 |
Cash at Beginning of Period | 150.47 | 193.07 | 239.40 | 195.72 | 139.75 |
Cash at End of Period | 467.29 | 150.47 | 193.07 | 239.40 | 195.72 |
Diluted Net EPS | 1.07 | 1.85 | 1.44 | 1.01 | 1.52 |
Fiscal Year End for Globus Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 122.87 | 107.84 | 106.84 | 49.13 |
Depreciation/Amortization & Depletion | NA | 225.36 | 93.37 | 36.97 | 18.59 |
Net Change from Assets/Liabilities | NA | -116.60 | -71.20 | -69.61 | -21.11 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 11.87 | 8.82 | 14.14 | 6.70 |
Net Cash From Operating Activities | NA | 243.50 | 138.83 | 88.34 | 53.31 |
Property & Equipment | NA | -78.27 | -55.39 | -33.86 | -15.99 |
Acquisition/ Disposition of Subsidiaries | NA | -296.03 | -296.03 | -2.66 | -2.66 |
Investments | NA | 677.27 | 333.77 | 99.74 | 29.65 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 302.97 | -17.65 | 63.21 | 10.99 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -213.17 | 11.36 | 8.06 | 4.86 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -18.66 | -5.91 | -4.03 | -1.92 |
Net Cash from Financing Activities | NA | -231.82 | 5.45 | 4.02 | 2.94 |
Effect of Exchange Rate Changes | NA | 2.18 | 2.53 | 0.41 | -0.03 |
Net Change In Cash & Equivalents | NA | 316.83 | 129.15 | 155.99 | 67.22 |
Cash at Beginning of Period | NA | 150.47 | 150.47 | 150.47 | 150.47 |
Cash at End of Period | NA | 467.29 | 279.62 | 306.45 | 217.69 |
Diluted Net EPS | NA | 0.01 | 0.01 | 0.57 | 0.48 |